These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5820316)

  • 21. [Burn toxins].
    VILJANTO J; NANTO V
    Duodecim; 1962; 78():700-2. PubMed ID: 13997248
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of glucocorticoid therapy on water-electrolyte balance in burn cachexia].
    Dolgina MI; Lantsberg LA
    Eksp Khir Anesteziol; 1966; 11(5):71-4. PubMed ID: 5995794
    [No Abstract]   [Full Text] [Related]  

  • 23. [Disturbed cellular energy metabolism in burns. Studies of rat liver].
    Schölmerich J; Kremer B; Schmidt K; Setyadharma H; Schoenenberger GA
    Acta Biol Med Ger; 1980; 39(10):1051-72. PubMed ID: 7223255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On a study of several toxic and serological modifications in the blood of burned subjects].
    Shokanbaev AN
    Patol Fiziol Eksp Ter; 1966; 10(1):32-5. PubMed ID: 5240479
    [No Abstract]   [Full Text] [Related]  

  • 25. [Functional state of mitochondria during early burn toxemia and exposure to middle molecular weight blood peptides].
    Riabinin VE; Lifshits RI; Charnaia LF; Val'dman BM; Efimenko GP
    Vopr Med Khim; 1984; 30(3):113-6. PubMed ID: 6474934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urinary excretion of toxic peptides in patients with thermal burns].
    Salomatin VV; Lifshits RI
    Vopr Med Khim; 1984; 30(3):120-4. PubMed ID: 6474936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems of the severely burnt patient.
    Allgöwer M
    Bull Soc Int Chir; 1973; 32(3):287-9. PubMed ID: 4746119
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction.
    Barber RC; Maass DL; White DJ; Chang LY; Horton JW
    Shock; 2008 Dec; 30(6):705-13. PubMed ID: 18461018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunotherapeutic studies with an experimental model in mice using a new burn toxin].
    Städtler K; Allgöwer M; Cueni LB; Schoenenberger GA
    Res Exp Med (Berl); 1972; 158(1):34-42. PubMed ID: 5053064
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of middle mass molecules from blood sera of patients with burns on the process of lipid peroxidation].
    Tupikova ZA
    Vopr Med Khim; 1983; 29(3):108-11. PubMed ID: 6880112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection.
    Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER
    Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of substances toxic to adrenalectomized mice in killed pneumococcal cultures (short report)].
    Anatoliĭ SA
    Biull Eksp Biol Med; 1967 Mar; 63(3):87-8. PubMed ID: 4393486
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective effect of previous burn on murine endotoxemia.
    Spillert CR; Machiaverna FE; Spillert MJ; Rush BF; Lazaro EJ
    Am Surg; 1984 Dec; 50(12):653-5. PubMed ID: 6391312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on isolation of a toxic substance from human and animal skin burned in vitro.
    Kwiek S; Kubica J; Rysińska A; Grzybowski J; Witecki J; Bukowska B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):69-77. PubMed ID: 7283679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased burn-induced immunosuppression in lipopolysaccharide-resistant mice.
    Jobin N; Garrel DR; Bernier J
    Cell Immunol; 2000 Mar; 200(2):65-75. PubMed ID: 10753497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating toxins in human disease: a viable concept?
    Ninnemann JL; Ozkan AN
    Ann Plast Surg; 1985 Feb; 14(2):155-7. PubMed ID: 3888035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of immune sorption to isolate burn toxin].
    Movshev BE
    Vopr Med Khim; 1981; 27(4):560-6. PubMed ID: 7027618
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological alterations following thermic injury ].
    Sauer H; Sauer D
    Allerg Immunol (Leipz); 1981; 27(3):139-44. PubMed ID: 6181670
    [No Abstract]   [Full Text] [Related]  

  • 39. The cellular basis of post-burn immunosuppression: macrophages and mediators.
    Schwacha MG; Chaudry IH
    Int J Mol Med; 2002 Sep; 10(3):239-43. PubMed ID: 12165794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
    Pallua N; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.